Open AccessCASE REPORT: PATHOLOGICAL COMPLETE RESPONSE IN BREAST IN A PATIENT WITH METASTATIC BREAST CANCER TREATED WITH ANASTROZOLE
Author(s) -
Paola Ferreira de Freitas,
Renata Borges de Aquino,
André Mattar,
Jorge Yoshinori Shida,
Luíz Henrique Gebrim
Publication year - 2021
Publication title -
mastology
Language(s) - English
Resource type - Conference proceedings
eISSN - 2594-5408
pISSN - 2594-5394
DOI - 10.29289/259453942021v31s2088
Subject(s) - anastrozole , breast cancer , medicine , metastatic breast cancer , oncology , aromatase , aromatase inhibitor , pathological , chemotherapy , cancer
Background: De novo metastatic breast cancer is seldomly encountered in patients visiting doctor’s clinics for the first time. This article reports a case of cervical/submandibular metastatic breast cancer treated with neoadjuvant endocrine therapy (NET) with anastrozole (ANA). Case description: We herein report on a patient affected by HR+, HER2−, and metastatic breast cancer treated with NET that presented after 6 months with the possibility of breast-conserving surgery due to clinical and radiological complete response, revealing after surgery pathological complete response. Conclusion: Even for patients with metastatic luminal breast cancer, NET with an aromatase inhibitor, especially ANA, is a good option for postmenopausal women with fewer side effects and allowing for breast-conserving surgery with less morbidity when comparing with chemotherapy and yet yielding good results.